RU2015132569A - Полимиксины, композиции с ними, способы получения и способы применения - Google Patents
Полимиксины, композиции с ними, способы получения и способы применения Download PDFInfo
- Publication number
- RU2015132569A RU2015132569A RU2015132569A RU2015132569A RU2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A
- Authority
- RU
- Russia
- Prior art keywords
- hplc
- octanoyl
- methyl
- composition
- methylheptanoyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 16
- 238000000034 method Methods 0.000 title claims 4
- -1 methylheptanoyl Chemical group 0.000 claims 32
- 238000004128 high performance liquid chromatography Methods 0.000 claims 26
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 6
- 108010040201 Polymyxins Proteins 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 4
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 241000588626 Acinetobacter baumannii Species 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- 241000588747 Klebsiella pneumoniae Species 0.000 claims 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 2
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 241000588915 Klebsiella aerogenes Species 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229940092559 enterobacter aerogenes Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361751341P | 2013-01-11 | 2013-01-11 | |
| US61/751,341 | 2013-01-11 | ||
| US201361904793P | 2013-11-15 | 2013-11-15 | |
| US61/904,793 | 2013-11-15 | ||
| PCT/EP2014/050320 WO2014108469A1 (en) | 2013-01-11 | 2014-01-09 | Polymyxins, compositions, methods of making and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015132569A true RU2015132569A (ru) | 2017-02-14 |
Family
ID=50101865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015132569A RU2015132569A (ru) | 2013-01-11 | 2014-01-09 | Полимиксины, композиции с ними, способы получения и способы применения |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10640536B2 (enExample) |
| EP (1) | EP2943503B1 (enExample) |
| JP (1) | JP6316846B2 (enExample) |
| KR (1) | KR20150107793A (enExample) |
| CN (1) | CN104918951B (enExample) |
| AU (1) | AU2014204873B2 (enExample) |
| BR (1) | BR112015016548A2 (enExample) |
| CA (1) | CA2895910C (enExample) |
| EA (1) | EA027067B1 (enExample) |
| ES (1) | ES2641017T3 (enExample) |
| HU (1) | HUE034562T2 (enExample) |
| IL (1) | IL239840A (enExample) |
| MX (1) | MX360905B (enExample) |
| PT (1) | PT2943503T (enExample) |
| RU (1) | RU2015132569A (enExample) |
| SI (1) | SI2943503T1 (enExample) |
| TW (1) | TWI613219B (enExample) |
| UA (1) | UA117673C2 (enExample) |
| WO (1) | WO2014108469A1 (enExample) |
| ZA (1) | ZA201504565B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10640536B2 (en) | 2013-01-11 | 2020-05-05 | Xellia Pharmaceuticals Aps | Polymyxins, compositions, methods of making and methods of use |
| TW201522364A (zh) * | 2013-06-07 | 2015-06-16 | Xellia Pharmaceuticals Aps | 黏菌素甲磺酸鈉（ｃｍｓ）之定性方法 |
| BR112017000228A2 (pt) * | 2014-07-09 | 2017-10-31 | Xellia Pharmaceuticals Aps | polimixinas de baixa substituição e suas composições. |
| EP3718571A1 (en) | 2014-10-03 | 2020-10-07 | Xellia Pharmaceuticals ApS | Compositions |
| TR201906108T4 (tr) | 2014-10-03 | 2019-05-21 | Xellia Pharmaceuticals Aps | İnhalasyon cihazı. |
| US9771394B2 (en) | 2014-12-16 | 2017-09-26 | Micurx Pharmaceuticals, Inc. | Antimicrobial polymyxins for treatment of bacterial infections |
| FI126143B (en) * | 2015-01-15 | 2016-07-15 | Northern Antibiotics Oy | Polymyxine derivative and its uses |
| CA3000032A1 (en) * | 2015-09-29 | 2017-04-06 | Monash University | Antimicrobial polymyxin derivative compounds |
| CN109996806B (zh) * | 2016-12-09 | 2021-11-02 | 正大天晴药业集团股份有限公司 | 高效价的多黏菌素e2甲磺酸钠 |
| US20230141981A1 (en) | 2020-01-21 | 2023-05-11 | Shanghai Micurx Pharmaceuticals Co., Ltd | Novel compounds and composition for targeted therapy of kidney-associated cancers |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1062895A (en) | 1962-12-13 | 1967-03-22 | Wellcome Found | Sulphomethyl derivatives of polymxin |
| DE1906699A1 (de) | 1968-02-12 | 1970-02-05 | Pfizer | Neue Polymyxinderivate und Verfahren zu deren Herstellung |
| FR1586834A (enExample) * | 1968-02-12 | 1970-03-06 | ||
| JPH02504003A (ja) * | 1988-04-07 | 1990-11-22 | シャンブロム，エドワード | 非トロンボゲン形成性脈管内タイムリリースカテーテル |
| JP2001505557A (ja) | 1996-11-15 | 2001-04-24 | パソジェネシス コーポレイション | 肺感染を処置するための、純粋な生物学的活性コリスチン、その成分、およびコリスチン処方物 |
| US5767068A (en) | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| EP1320355B1 (en) | 2001-05-18 | 2006-04-05 | Chiron Corporation | System for delivering a tobramycin formulation |
| US20040022740A1 (en) | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| JP2009513623A (ja) * | 2005-10-28 | 2009-04-02 | アーチ ファーマラブズ リミテッド | 塩酸ジェムシタビンの改良された製造方法 |
| WO2008025560A1 (en) | 2006-09-01 | 2008-03-06 | Pari Pharma Gmbh | Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy |
| US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| WO2012168820A1 (en) | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| US10640536B2 (en) | 2013-01-11 | 2020-05-05 | Xellia Pharmaceuticals Aps | Polymyxins, compositions, methods of making and methods of use |
| TW201522364A (zh) | 2013-06-07 | 2015-06-16 | Xellia Pharmaceuticals Aps | 黏菌素甲磺酸鈉（ｃｍｓ）之定性方法 |
| BR112017000228A2 (pt) | 2014-07-09 | 2017-10-31 | Xellia Pharmaceuticals Aps | polimixinas de baixa substituição e suas composições. |
| EP3718571A1 (en) | 2014-10-03 | 2020-10-07 | Xellia Pharmaceuticals ApS | Compositions |
-
2014
- 2014-01-09 US US14/760,222 patent/US10640536B2/en active Active
- 2014-01-09 ES ES14704292.3T patent/ES2641017T3/es active Active
- 2014-01-09 CN CN201480004714.8A patent/CN104918951B/zh active Active
- 2014-01-09 CA CA2895910A patent/CA2895910C/en active Active
- 2014-01-09 AU AU2014204873A patent/AU2014204873B2/en active Active
- 2014-01-09 EA EA201591280A patent/EA027067B1/ru unknown
- 2014-01-09 SI SI201430386T patent/SI2943503T1/sl unknown
- 2014-01-09 RU RU2015132569A patent/RU2015132569A/ru not_active Application Discontinuation
- 2014-01-09 KR KR1020157021592A patent/KR20150107793A/ko not_active Withdrawn
- 2014-01-09 PT PT147042923T patent/PT2943503T/pt unknown
- 2014-01-09 HU HUE14704292A patent/HUE034562T2/en unknown
- 2014-01-09 UA UAA201507907A patent/UA117673C2/uk unknown
- 2014-01-09 JP JP2015552046A patent/JP6316846B2/ja active Active
- 2014-01-09 WO PCT/EP2014/050320 patent/WO2014108469A1/en not_active Ceased
- 2014-01-09 EP EP14704292.3A patent/EP2943503B1/en active Active
- 2014-01-09 MX MX2015008878A patent/MX360905B/es active IP Right Grant
- 2014-01-09 BR BR112015016548A patent/BR112015016548A2/pt not_active Application Discontinuation
- 2014-01-10 TW TW103101009A patent/TWI613219B/zh active
-
2015
- 2015-06-24 ZA ZA2015/04565A patent/ZA201504565B/en unknown
- 2015-07-08 IL IL239840A patent/IL239840A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014204873B2 (en) | 2017-07-06 |
| BR112015016548A2 (pt) | 2017-07-11 |
| TWI613219B (zh) | 2018-02-01 |
| ZA201504565B (en) | 2016-11-30 |
| EP2943503A1 (en) | 2015-11-18 |
| EP2943503B1 (en) | 2017-08-23 |
| PT2943503T (pt) | 2017-09-28 |
| US20160002296A1 (en) | 2016-01-07 |
| AU2014204873A1 (en) | 2015-07-09 |
| EA027067B1 (ru) | 2017-06-30 |
| HUE034562T2 (en) | 2018-03-28 |
| TW201429995A (zh) | 2014-08-01 |
| UA117673C2 (uk) | 2018-09-10 |
| IL239840A (en) | 2017-09-28 |
| MX360905B (es) | 2018-11-21 |
| CN104918951A (zh) | 2015-09-16 |
| ES2641017T3 (es) | 2017-11-07 |
| IL239840A0 (en) | 2015-08-31 |
| KR20150107793A (ko) | 2015-09-23 |
| SI2943503T1 (sl) | 2017-11-30 |
| JP2016505007A (ja) | 2016-02-18 |
| CA2895910C (en) | 2021-12-21 |
| EA201591280A1 (ru) | 2015-12-30 |
| JP6316846B2 (ja) | 2018-04-25 |
| WO2014108469A1 (en) | 2014-07-17 |
| US10640536B2 (en) | 2020-05-05 |
| CN104918951B (zh) | 2018-03-30 |
| CA2895910A1 (en) | 2014-07-17 |
| MX2015008878A (es) | 2015-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015132569A (ru) | Полимиксины, композиции с ними, способы получения и способы применения | |
| JP2016505007A5 (enExample) | ||
| AR121016A2 (es) | Sales de fenotiazindiaminio y su uso | |
| MX385731B (es) | Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
| EA201800064A1 (ru) | 1,1,1-трифтор-3-гидроксипропан-2-ил карбаматные производные и 1,1,1-трифтор-4-гидроксибутан-2-ил карбаматные производные в качестве ингибиторов magl | |
| RU2015138796A (ru) | Способы и составы для лечения респираторных заболеваний | |
| FI3616695T3 (fi) | Menetelmät keuhkojen sisäisten infektioiden hoitamiseksi | |
| EA202090604A1 (ru) | Хроманмонобактамовые соединения для лечения бактериальных инфекций | |
| JP2017510580A5 (enExample) | ||
| EA201490864A1 (ru) | Производные (4-фенилимидазол-2-ил)этиламина в качестве модуляторов натриевых каналов | |
| HRP20171512T1 (hr) | Derivati betulina | |
| JP2016503052A5 (enExample) | ||
| BR112014004704A2 (pt) | compostos antibacterianos e métodos de uso | |
| JP2013542992A5 (enExample) | ||
| EA201790337A1 (ru) | Кристаллические формы ингибиторов глутаминазы | |
| HRP20200938T1 (hr) | Kombinacija koja sadrži zidovudin i polimiksin | |
| EA201890771A1 (ru) | Соли и твердые формы монобактамного антибиотика | |
| EA201590022A1 (ru) | Новые производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные гетероциклами, в качестве противовирусных средств против респираторного синцитиального вируса | |
| EA202091118A1 (ru) | Антибактериальные соединения | |
| RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения | |
| EA201791138A1 (ru) | Фармацевтическая композиция, ее приготовление и применения | |
| ME02405B (me) | Spojevi pirazola као inhibitori sglt1 | |
| EA201691271A1 (ru) | Соединения [1 ,2,4]триазоло[1 ,5-a]пиримидина в качестве ингибиторов протозойной протеосомы для лечения паразитарного заболевания, такого как лейшманиоз | |
| EA201792264A1 (ru) | Способы лечения воспалительных заболеваний |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20171109 |